Carlyle Group Inc. - Q4 2019 holdings

$1.51 Billion is the total value of Carlyle Group Inc.'s 12 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 16.7% .

 Value Shares↓ Weighting
EVA BuyEnviva Partners LP$475,479,000
+33.4%
12,744,020
+14.2%
31.48%
+37.4%
LBRT SellLiberty Oilfield Svcs Inc$378,692,000
-12.2%
34,054,996
-14.4%
25.07%
-9.5%
WAIR  Wesco Aircraft Hldgs Inc$254,528,000
+0.1%
23,096,8820.0%16.85%
+3.1%
ONE  Onesmart Intl Ed Group Ltdsponsored ads$206,884,000
-9.7%
31,017,1420.0%13.70%
-7.0%
CHK  Chesapeake Energy Corp$147,744,000
-39.4%
172,897,3870.0%9.78%
-37.6%
SMHI  Seacor Marine Hldgs Inc$14,686,000
+9.7%
1,064,9760.0%0.97%
+13.0%
CIH  China Index Hldgs Ltdspnsrd ads a$8,960,000
-6.7%
2,461,5380.0%0.59%
-3.9%
SFUN NewFang Hldgs Ltdadr new$7,040,0002,461,538
+100.0%
0.47%
REI  Ring Energy Inc$6,927,000
+61.0%
2,623,9480.0%0.46%
+65.7%
CDEV  Centennial Resource Dev Inccl a$5,865,000
+2.3%
1,269,5820.0%0.39%
+5.4%
SQBG  Sequential Brnds Group Inc N$2,182,000
+54.3%
6,369,8120.0%0.14%
+58.2%
SG  Sirius International Insuran$1,523,000
+7.7%
174,1700.0%0.10%
+11.0%
SFUN ExitFang Hldgs Ltdadr$0-2,461,538
-100.0%
-0.35%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wesco Aircraft Hldgs Inc28Q4 201916.8%
Seacor Marine Hldgs Inc22Q3 20231.1%
Enviva Partners LP21Q2 202031.5%
Enduro Rty Tr21Q1 20182.8%
USA Compression Partners LP20Q2 201828.5%
Pattern Energy Group Inc20Q3 201816.2%
Concord Med Svcs Hldgs Ltd19Q3 20171.1%
Superior Energy Svcs Inc19Q3 20170.7%
Cobalt Intl Energy Inc17Q1 201711.0%
Sequential Brnds Group Inc N17Q1 20201.7%

View Carlyle Group Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Carlyle Group Inc. Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Complete Solaria, Inc.September 22, 20232,745,8795.7%
Carlyle Credit Income FundSeptember 14, 20234,785,62841.0%
eFFECTOR Therapeutics, Inc.August 18, 20234,829,8917.8%
Vera Therapeutics, Inc.August 02, 20231,872,7644.2%
Reneo Pharmaceuticals, Inc.May 09, 20232,730,4578.2%
EXICURE, INC.April 13, 2023287,1373.4%
SPRUCE BIOSCIENCES, INC.February 23, 20233,734,5189.2%
Vaxcyte, Inc.February 10, 20232,070,7242.6%
NuCana plcAugust 11, 20223,353,1346.4%
QuidelOrtho CorpJune 06, 202212,460,18318.6%

View Carlyle Group Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
ARS2024-04-18
DEF 14A2024-04-18
DEFA14A2024-04-18
8-K2024-04-03
PRE 14A2024-04-03
42024-04-02
SC 13G2024-03-29
8-K2024-03-27
42024-03-05
SC 13D/A2024-03-05

View Carlyle Group Inc.'s complete filings history.

Compare quarters

Export Carlyle Group Inc.'s holdings